Shares of Transcat, Inc. (NASDAQ:TRNS – Get Free Report) have earned an average recommendation of “Moderate Buy” from the three brokerages that are covering the stock, MarketBeat Ratings reports. One research analyst has rated the stock with a hold recommendation and two have issued a buy recommendation on the company. The average twelve-month price target among brokers that have updated their coverage on the stock in the last year is $134.50.
TRNS has been the topic of a number of recent research reports. Oppenheimer boosted their price objective on Transcat from $125.00 to $160.00 and gave the stock an “outperform” rating in a research note on Wednesday. Northland Capmk lowered Transcat from a “strong-buy” rating to a “hold” rating in a research note on Wednesday. Northland Securities lowered Transcat from an “outperform” rating to a “market perform” rating in a research note on Wednesday. TheStreet raised Transcat from a “c+” rating to a “b” rating in a research note on Wednesday, January 31st. Finally, HC Wainwright upped their price target on Transcat from $124.00 to $156.00 and gave the company a “buy” rating in a research note on Wednesday.
View Our Latest Report on TRNS
Transcat Stock Performance
Shares of NASDAQ:TRNS opened at $142.18 on Thursday. The company has a debt-to-equity ratio of 0.01, a current ratio of 3.37 and a quick ratio of 2.81. The business’s 50 day moving average price is $113.21 and its 200-day moving average price is $105.94. The firm has a market capitalization of $1.26 billion, a PE ratio of 89.42 and a beta of 0.61. Transcat has a 1 year low of $81.26 and a 1 year high of $147.00.
Insider Activity at Transcat
In related news, CEO Lee D. Rudow sold 3,343 shares of the business’s stock in a transaction on Monday, May 20th. The stock was sold at an average price of $124.12, for a total value of $414,933.16. Following the sale, the chief executive officer now owns 103,692 shares in the company, valued at approximately $12,870,251.04. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. In related news, CEO Lee D. Rudow sold 3,343 shares of the business’s stock in a transaction on Monday, May 20th. The stock was sold at an average price of $124.12, for a total value of $414,933.16. Following the sale, the chief executive officer now owns 103,692 shares in the company, valued at approximately $12,870,251.04. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, CEO Lee D. Rudow sold 2,373 shares of the company’s stock in a transaction dated Saturday, March 30th. The stock was sold at an average price of $111.43, for a total value of $264,423.39. Following the sale, the chief executive officer now owns 103,688 shares in the company, valued at approximately $11,553,953.84. The disclosure for this sale can be found here. Company insiders own 4.20% of the company’s stock.
Institutional Investors Weigh In On Transcat
Several large investors have recently bought and sold shares of TRNS. State Board of Administration of Florida Retirement System purchased a new stake in Transcat during the 3rd quarter worth about $207,000. Arizona State Retirement System acquired a new position in shares of Transcat during the 3rd quarter worth about $213,000. Virtu Financial LLC acquired a new position in shares of Transcat during the 1st quarter worth about $224,000. Quantbot Technologies LP boosted its position in shares of Transcat by 118.2% during the 3rd quarter. Quantbot Technologies LP now owns 2,370 shares of the scientific and technical instruments company’s stock worth $232,000 after acquiring an additional 1,284 shares in the last quarter. Finally, Price T Rowe Associates Inc. MD boosted its position in shares of Transcat by 13.8% during the 1st quarter. Price T Rowe Associates Inc. MD now owns 2,347 shares of the scientific and technical instruments company’s stock worth $262,000 after acquiring an additional 284 shares in the last quarter. Hedge funds and other institutional investors own 98.34% of the company’s stock.
Transcat Company Profile
(Get Free Report
Transcat, Inc provides calibration and laboratory instrument services in the United States, Canada, and internationally. It operates through two segments: Service and Distribution. The Service segment offers calibration, repair, inspection, analytical qualification, preventative maintenance, consulting, and other related services.
See Also
- Five stocks we like better than Transcat
- Stock Average Calculator
- Analog Devices Extends Rally: Signals Start to Cyclical Recovery
- Profitably Trade Stocks at 52-Week Highs
- TJX Companies Can Hit New Highs; Double-Digit Upside to Follow
- Learn Technical Analysis Skills to Master the Stock Market
- A Hidden Gem Retailer With 20% Upside